ARTLW vs. ATNFW, SXTPW, DRTSW, APLMW, BCDAW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW
Should you be buying Artelo Biosciences stock or one of its competitors? The main competitors of Artelo Biosciences include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
Artelo Biosciences (NASDAQ:ARTLW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and community ranking.
In the previous week, Artelo Biosciences' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Artelo Biosciences and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
Artelo Biosciences and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.
Get Artelo Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARTLW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ARTLW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ARTLW vs. The Competition
Artelo Biosciences Competitors List
Related Companies and Tools
